Jessica Allegretti

Associate Director,Crohn's and Colitis Center · Beth Israel Deaconess Medical Center

Credentials: · · · ·

History

Research Training in Gastrointestinal and Hepatic Diseases
National Institute of Diabetes and Digestive and Kidney Diseases · T32
Contact PI · $776.3K · Brigham and Women's Hospital
2023–2028
Low Dose Interleukin-2 for Regulatory T Cell Modulation and the Treatment of Crohnâs Disease
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $2.8M · Boston Children's Hospital
2020–2027
Understanding Clostridium Difficile Infection in Patients with Inflammatory Bowel Disease
National Institute of Diabetes and Digestive and Kidney Diseases · K23
Contact PI · $983.3K · Brigham and Women's Hospital
2020–2026
Low Dose Interleukin 2 for the Expansion of Regulatory T Cells and the Treatment of Moderate to Severe Ulcerative Colitis
National Institute of Diabetes and Digestive and Kidney Diseases · R21
PI · $408.3K · Boston Children's Hospital
2018–2021

Pilot Trial of Xylitol for C. Difficile De-Colonization in Patients With Inflammatory Bowel Disease
Principal investigator · Not yet recruiting · Early phase 1
Brigham and Women's Hospital
2026–2031
Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease
Principal investigator · Not yet recruiting · Phase 4
Brigham and Women's Hospital
2026–2031
Xylitol Use for Decolonization of C. Difficile in Patients With IBD
Principal investigator · Not yet recruiting · Phase 1
Brigham and Women's Hospital
2026–2033
Low Dose IL-2 for the Treatment of Crohn's Disease
Principal investigator · Recruiting · Phase 1, Phase 2
Boston Children's Hospital
2021–2027